# CIrCuLAting Dna ESr1 Gene Mutations Analysis

> **NCT03318263** · NA · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 146 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** next-generation sequencing (NGS)

## Key facts

- **NCT ID:** NCT03318263
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-07
- **Primary completion:** 2022-12-22
- **Final completion:** 2022-12-22
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03318263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03318263, "CIrCuLAting Dna ESr1 Gene Mutations Analysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03318263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*